|
G |
Ache |
acetylcholinesterase |
increases activity |
ISO |
chlorite results in increased activity of ACHE protein |
CTD |
PMID:27478981 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Cat |
catalase |
decreases activity |
ISO |
chlorite results in decreased activity of CAT protein |
CTD |
PMID:27478981 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases activity |
ISO |
chlorite results in decreased activity of G6PD protein |
CTD |
PMID:27478981 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity |
ISO |
chlorite results in decreased activity of GSR protein |
CTD |
PMID:27478981 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
EXP |
chlorite promotes the reaction [Bromates results in increased phosphorylation of H2AX protein] |
CTD |
PMID:21864635 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Ldhb |
lactate dehydrogenase B |
increases activity |
ISO |
chlorite results in increased activity of LDHB protein |
CTD |
PMID:27478981 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases activity |
ISO |
chlorite results in increased activity of SOD1 protein |
CTD |
PMID:27478981 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases activity |
ISO |
chlorite results in decreased activity of TXNRD1 protein |
CTD |
PMID:27478981 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
|
G |
Aqp1 |
aquaporin 1 |
affects expression |
EXP |
perchlorate affects the expression of AQP1 mRNA |
CTD |
PMID:21623536 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression |
EXP |
perchlorate results in decreased expression of BDNF mRNA |
CTD |
PMID:35385113 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
decreases expression |
EXP |
perchlorate results in decreased expression of BMP7 mRNA |
CTD |
PMID:35385113 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
decreases expression |
EXP |
perchlorate results in decreased expression of CAMK4 mRNA |
CTD |
PMID:35385113 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases activity |
ISO |
perchlorate results in decreased activity of CA1 protein |
CTD |
PMID:15664814 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases activity |
ISO |
perchlorate results in decreased activity of CA2 protein |
CTD |
PMID:15664814 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car5a |
carbonic anhydrase 5A |
decreases activity |
ISO |
perchlorate results in decreased activity of CA5A protein |
CTD |
PMID:15664814 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases activity |
ISO |
perchlorate results in decreased activity of CA9 protein |
CTD |
PMID:15664814 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
EXP |
perchlorate results in increased activity of CASP3 protein Sodium Iodide promotes the reaction [perchlorate results in increased activity of CASP3 protein] |
CTD |
PMID:11834455 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[sodium perchlorate results in increased abundance of perchlorate] which results in increased expression of FOS protein |
CTD |
PMID:30991129 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Mir133a1 |
microRNA 133a-1 |
multiple interactions |
ISO |
[Methimazole co-treated with perchlorate] results in increased expression of MIR133A1 mRNA |
CTD |
PMID:20808432 |
|
NCBI chr18:1,885,082...1,885,168
|
|
G |
Mir133b |
microRNA 133b |
multiple interactions |
ISO |
[Methimazole co-treated with perchlorate] results in increased expression of MIR133B mRNA |
CTD |
PMID:20808432 |
|
NCBI chr 9:23,098,134...23,098,217
Ensembl chr 9:23,098,134...23,098,217
|
|
G |
Mir135a |
microRNA 135a |
multiple interactions |
ISO |
[Methimazole co-treated with perchlorate] results in increased expression of MIR135A mRNA |
CTD |
PMID:20808432 |
|
NCBI chr 7:26,611,990...26,612,089
Ensembl chr 7:26,611,990...26,612,089
|
|
G |
Mir135b |
microRNA 135b |
multiple interactions |
ISO |
[Methimazole co-treated with perchlorate] results in increased expression of MIR135B mRNA |
CTD |
PMID:20808432 |
|
NCBI chr13:43,638,857...43,638,953
Ensembl chr13:43,638,857...43,638,953
|
|
G |
Mir148a |
microRNA 148a |
multiple interactions |
ISO |
[Methimazole co-treated with perchlorate] results in decreased expression of MIR148A mRNA |
CTD |
PMID:20808432 |
|
NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
|
|
G |
Mir206 |
microRNA 206 |
multiple interactions |
ISO |
[Methimazole co-treated with perchlorate] results in increased expression of MIR206 mRNA |
CTD |
PMID:20808432 |
|
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
|
|
G |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
multiple interactions |
ISO |
perchlorate binds to and results in decreased activity of PAPSS1 protein |
CTD |
PMID:15065880 |
|
NCBI chr 2:220,040,343...220,114,399
Ensembl chr 2:220,040,312...220,114,395
|
|
G |
Pax8 |
paired box 8 |
decreases expression |
EXP |
perchlorate results in decreased expression of PAX8 mRNA |
CTD |
PMID:35385113 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
affects expression |
EXP |
perchlorate affects the expression of SLC22A3 mRNA |
CTD |
PMID:21623536 |
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
increases expression |
EXP |
perchlorate results in increased expression of SLC26A4 mRNA |
CTD |
PMID:35385113 |
|
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
increases expression affects expression decreases activity multiple interactions |
ISO EXP |
perchlorate results in increased expression of SLC5A5 protein perchlorate results in increased expression of SLC5A5 mRNA perchlorate affects the expression of SLC5A5 mRNA perchlorate results in decreased activity of SLC5A5 protein perchlorate inhibits the reaction [mibolerone promotes the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]]; perchlorate inhibits the reaction [SLC5A5 protein results in increased abundance of Sodium Iodide]; perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodides]; perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] |
CTD |
PMID:12601449 PMID:14633711 PMID:15347726 PMID:15850642 PMID:15941870 PMID:16987991 PMID:17332529 PMID:21623536 PMID:35385113 More...
|
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Tg |
thyroglobulin |
decreases expression |
ISO EXP |
perchlorate results in decreased expression of TG protein perchlorate results in decreased expression of TG mRNA |
CTD |
PMID:17332529 PMID:35385113 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Thrb |
thyroid hormone receptor beta |
decreases expression |
EXP |
perchlorate results in decreased expression of THRB mRNA |
CTD |
PMID:35385113 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tpo |
thyroid peroxidase |
increases expression |
EXP |
perchlorate results in increased expression of TPO mRNA |
CTD |
PMID:35385113 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
increases expression multiple interactions |
ISO |
perchlorate results in increased expression of TSHB protein [Iodides deficiency co-treated with perchlorate] results in increased expression of TSHB protein |
CTD |
PMID:17332529 PMID:20439182 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
decreases expression |
EXP |
perchlorate results in decreased expression of TSHR mRNA |
CTD |
PMID:35385113 |
|
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
|
|
|
G |
A2m |
alpha-2-macroglobulin |
decreases expression |
ISO |
potassium bromate results in decreased expression of A2M mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
EXP |
potassium bromate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP |
potassium bromate results in increased phosphorylation of AKT1 protein Squalene inhibits the reaction [potassium bromate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:33219891 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Anos1 |
anosmin 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:68,561,954...68,562,801
Ensembl chr10:68,561,954...68,562,801
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
potassium bromate results in increased expression of APEX1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
potassium bromate results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Areg |
amphiregulin |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
affects expression |
ISO |
potassium bromate affects the expression of ASNS mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of ATF3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATM mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of ATP2B3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
potassium bromate results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
potassium bromate results in increased expression of BAX mRNA Squalene promotes the reaction [potassium bromate results in increased expression of BAX protein] |
CTD |
PMID:30559759 PMID:33219891 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of BCL2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of BCL2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Blnk |
B-cell linker |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BLNK mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmf |
Bcl2 modifying factor |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BMF mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
ISO |
potassium bromate results in increased expression of BRCA1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of CA3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car6 |
carbonic anhydrase 6 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of CASP3 protein Squalene promotes the reaction [potassium bromate results in increased expression of CASP3 protein] |
CTD |
PMID:33219891 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases activity multiple interactions increases activity |
ISO EXP |
potassium bromate results in decreased activity of CAT protein vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] Arbutin inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Squalene inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of CAT protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:26296324 PMID:27074584 PMID:33219891 PMID:36284482 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of CCL20 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions increases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CCNB1 protein] |
CTD |
PMID:20067818 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccno |
cyclin O |
decreases expression |
ISO |
potassium bromate results in decreased expression of CCNO mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 2:44,630,873...44,633,912
Ensembl chr 2:44,626,369...44,633,914
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
increases expression |
EXP |
potassium bromate results in increased expression of CDHR1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases phosphorylation |
ISO |
potassium bromate results in increased phosphorylation of CDK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression affects methylation affects expression multiple interactions |
ISO EXP |
potassium bromate results in increased expression of CDKN1A mRNA; potassium bromate results in increased expression of CDKN1A protein potassium bromate affects the methylation of CDKN1A gene potassium bromate affects the expression of CDKN1A mRNA; potassium bromate affects the expression of CDKN1A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Azacitidine inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; trichostatin A inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] |
CTD |
PMID:20067818 PMID:23588252 PMID:23811332 PMID:25015661 PMID:30008028 PMID:30559759 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cfd |
complement factor D |
decreases expression |
EXP |
potassium bromate results in decreased expression of CFD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
potassium bromate results in increased expression of CHAC1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Cldn2 |
claudin 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CLDN2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
potassium bromate results in increased expression of CLU protein |
CTD |
PMID:23159986 PMID:23588252 PMID:23811332 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Coch |
cochlin |
decreases expression |
EXP |
potassium bromate results in decreased expression of COCH mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
EXP |
potassium bromate results in increased expression of COMT mRNA |
CTD |
PMID:23588252 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
increases expression |
EXP |
potassium bromate results in increased expression of CSRP3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cth |
cystathionine gamma-lyase |
increases methylation |
ISO |
potassium bromate results in increased methylation of CTH promoter |
CTD |
PMID:30559759 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
decreases expression increases expression |
EXP |
potassium bromate results in decreased expression of CYP2C7 mRNA potassium bromate results in increased expression of CYP2C7 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:237,332,641...237,388,714
Ensembl chr 1:237,332,659...237,388,709
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
increases expression |
ISO |
potassium bromate results in increased expression of DDB2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
potassium bromate results in increased expression of DDIT3 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dsc1 |
desmocollin 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,502,003...11,528,494
|
|
G |
Dusp2 |
dual specificity phosphatase 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of DUSP2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
|
|
G |
Egr4 |
early growth response 4 |
multiple interactions affects expression |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
ISO |
potassium bromate results in decreased expression of ERCC4 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
affects response to substance multiple interactions |
ISO |
ERCC6 protein affects the susceptibility to potassium bromate veliparib promotes the reaction [ERCC6 protein affects the susceptibility to potassium bromate] |
CTD |
PMID:25136123 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
potassium bromate results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
potassium bromate results in increased expression of FAS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbxo22 |
F-box protein 22 |
increases expression |
ISO |
potassium bromate results in increased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of FEN1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgb |
fibrinogen beta chain |
increases expression |
EXP |
potassium bromate results in increased expression of FGB mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgl2 |
fibrinogen-like 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of FGL2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fry |
FRY microtubule binding protein |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
potassium bromate results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fzd2 |
frizzled class receptor 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions decreases activity |
EXP |
Taurine inhibits the reaction [potassium bromate results in decreased activity of G6PD protein] |
CTD |
PMID:25213677 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
potassium bromate results in increased expression of GADD45A mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression increases methylation |
ISO |
potassium bromate results in increased expression of GCLM mRNA potassium bromate results in increased methylation of GCLM promoter |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
potassium bromate results in increased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
potassium bromate results in increased expression of GPR87 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of GPT protein Squalene inhibits the reaction [potassium bromate results in increased activity of GPT protein] |
CTD |
PMID:33219891 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grifin |
galectin-related inter-fiber protein |
decreases expression |
EXP |
potassium bromate results in decreased expression of GRIFIN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity multiple interactions |
ISO EXP |
potassium bromate results in decreased activity of GSR protein Squalene inhibits the reaction [potassium bromate results in decreased activity of GSR protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of GSR protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:33219891 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of GSTA5 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO EXP |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] potassium bromate results in increased phosphorylation of H2AX protein Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein]; trichostatin A inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein] |
CTD |
PMID:25015661 PMID:25693136 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression |
EXP |
potassium bromate results in increased expression of HAVCR1 mRNA; potassium bromate results in increased expression of HAVCR1 protein |
CTD |
PMID:23588252 PMID:23811332 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA] |
CTD |
PMID:25618551 PMID:30008028 PMID:30559759 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression decreases expression |
ISO |
potassium bromate results in increased expression of HNF4A mRNA potassium bromate results in decreased expression of HNF4A mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hp |
haptoglobin |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of HP mRNA [potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of HPRT1 gene |
CTD |
PMID:19853637 PMID:22539617 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
increases expression |
EXP |
potassium bromate results in increased expression of IGFBP1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IKZF2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:71,042,440...71,190,867
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IL18R1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of IL1B mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA] |
CTD |
PMID:23588252 PMID:26296324 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il24 |
interleukin 24 |
increases expression |
EXP |
potassium bromate results in increased expression of IL24 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of IL6 mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of KIRREL3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 8:32,865,779...33,407,555
Ensembl chr 8:32,862,776...33,405,676
|
|
G |
Klf15 |
KLF transcription factor 15 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of KLF15 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lgals12 |
galectin 12 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:204,832,065...204,842,759
Ensembl chr 1:204,832,065...204,842,759
|
|
G |
Lig3 |
DNA ligase 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of LIG3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:67,717,808...67,741,141
Ensembl chr10:67,717,812...67,798,414
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:20067818 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
ISO |
potassium bromate results in increased expression of MDM2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
potassium bromate results in increased expression of ME1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med1 |
mediator complex subunit 1 |
decreases phosphorylation |
ISO |
potassium bromate results in decreased phosphorylation of MED1 protein |
CTD |
PMID:25068892 |
|
NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
|
|
G |
Mir126b |
microRNA 126b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR126 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:9,415,087...9,415,159
|
|
G |
Mir134 |
microRNA 134 |
increases expression |
ISO |
potassium bromate results in increased expression of MIR134 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:128,748,908...128,748,980
|
|
G |
Mir137 |
microRNA 137 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR137 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:206,480,881...206,480,982
Ensembl chr 2:206,480,884...206,480,985
|
|
G |
Mir146b |
microRNA 146b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR146B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mir193a |
microRNA 193a |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR193A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir193b |
microRNA 193b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR193B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
|
|
G |
Mir205 |
microRNA 205 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR205 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:105,035,878...105,035,985
Ensembl chr13:105,035,878...105,035,985
|
|
G |
Mir21 |
microRNA 21 |
increases expression |
ISO |
potassium bromate results in increased expression of MIR21 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir23b |
microRNA 23b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR23B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir29b1 |
microRNA 29b-1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mir322 |
microRNA 322 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR424 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,806,594...132,806,688
Ensembl chr X:132,806,594...132,806,688
|
|
G |
Mir331 |
microRNA 331 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR331 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:28,527,390...28,527,485
Ensembl chr 7:28,527,390...28,527,485
|
|
G |
Mir542 |
microRNA 542 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR542 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of MMP2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of MMP2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
EXP |
potassium bromate results in increased expression of MTHFD2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
potassium bromate results in decreased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mutyh |
mutY DNA glycosylase |
decreases expression |
ISO |
potassium bromate results in decreased expression of MUTYH mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
|
|
G |
Myh1 |
myosin heavy chain 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:51,885,913...51,909,699
Ensembl chr10:51,885,913...51,946,295
|
|
G |
Myh2 |
myosin heavy chain 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MYLK3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr19:21,685,085...21,743,587
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Nebl |
nebulette |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
potassium bromate results in increased expression of NQO1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases response to substance increases response to substance |
ISO |
OGG1 gene mutant form results in decreased susceptibility to potassium bromate OGG1 protein results in increased susceptibility to potassium bromate |
CTD |
PMID:25693136 PMID:34196753 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Ostn |
osteocrin |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
decreases expression |
ISO |
potassium bromate results in decreased expression of PHGDH mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Plch2 |
phospholipase C, eta 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:165,544,209...165,613,769
Ensembl chr 5:165,544,200...165,602,356
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
ISO |
potassium bromate results in decreased expression of PNKP mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:95,341,465...95,346,921
Ensembl chr 1:95,341,620...95,346,920
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
ISO |
potassium bromate results in increased expression of PPM1D mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
decreases methylation |
ISO |
potassium bromate results in decreased methylation of PPP1R15A promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prg4 |
proteoglycan 4 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PRG4 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr13:62,487,257...62,504,657
Ensembl chr13:62,487,257...62,504,119
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of PTGS2 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA] |
CTD |
PMID:26296324 PMID:27082013 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PTPN22 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
|
|
G |
Rab3gap2 |
RAB3 GTPase activating non-catalytic protein subunit 2 |
increases expression |
EXP |
potassium bromate results in increased expression of RAB3GAP2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:96,757,430...96,828,930
Ensembl chr13:96,757,460...96,829,478
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
EXP |
Squalene inhibits the reaction [potassium bromate results in increased expression of RELA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
increases expression |
EXP |
potassium bromate results in increased expression of REN1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Retn |
resistin |
decreases expression |
EXP |
potassium bromate results in decreased expression of RETN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Robo3 |
roundabout guidance receptor 3 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of ROBO3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:37,133,542...37,151,674
Ensembl chr 8:37,133,916...37,151,315
|
|
G |
Rps27l |
ribosomal protein S27-like |
increases expression |
ISO |
potassium bromate results in increased expression of RPS27L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
potassium bromate results in increased expression of RRM2B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
increases expression |
EXP |
potassium bromate results in increased expression of S100A8 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
decreases expression |
EXP |
potassium bromate results in decreased expression of S100A9 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
potassium bromate results in decreased expression of SCD1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sertad1 |
SERTA domain containing 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Sesn1 |
sestrin 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SESN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
potassium bromate results in increased expression of SFN mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
decreases expression |
EXP |
potassium bromate results in decreased expression of SLC26A4 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc26a7 |
solute carrier family 26 member 7 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:27,884,400...28,021,865
Ensembl chr 5:27,887,042...28,021,658
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
potassium bromate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
ISO |
potassium bromate results in increased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of SLCO2B1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases activity decreases activity multiple interactions |
ISO EXP |
potassium bromate results in increased activity of SOD1 protein potassium bromate results in decreased activity of SOD1 protein Arbutin inhibits the reaction [potassium bromate results in decreased activity of SOD1 protein] |
CTD |
PMID:22012894 PMID:36284482 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] |
CTD |
PMID:25618551 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spata22 |
spermatogenesis associated 22 |
decreases expression |
EXP |
potassium bromate results in decreased expression of SPATA22 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP ISO |
potassium bromate results in increased expression of SPP1 mRNA; potassium bromate results in increased expression of SPP1 protein |
CTD |
PMID:23588252 PMID:23811332 PMID:30008028 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SQSTM1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SRXN1 mRNA |
CTD |
PMID:22003191 PMID:30008028 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases expression |
EXP |
potassium bromate results in increased expression of SULT2A1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tigar |
TP53 induced glycolysis regulatory phosphatase |
increases expression |
ISO |
potassium bromate results in increased expression of TIGAR mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:159,927,136...159,946,077
Ensembl chr 4:159,927,139...159,946,029
|
|
G |
Tk1 |
thymidine kinase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of TK1 gene |
CTD |
PMID:19853637 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tmem163 |
transmembrane protein 163 |
decreases expression |
EXP |
potassium bromate results in decreased expression of TMEM163 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
increases expression |
ISO |
potassium bromate results in increased expression of TNFSF9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Tns1 |
tensin 1 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
|
|
G |
Top3b |
DNA topoisomerase III beta |
decreases expression |
ISO |
potassium bromate results in decreased expression of TOP3B mRNA |
CTD |
PMID:22539617 |
|
NCBI chr11:84,097,018...84,125,474
Ensembl chr11:84,097,026...84,125,392
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases phosphorylation |
ISO EXP |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein] |
CTD |
PMID:20067818 PMID:25015661 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
increases methylation increases expression |
ISO |
potassium bromate results in increased methylation of TP53INP1 promoter potassium bromate results in increased expression of TP53INP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
increases expression |
ISO |
potassium bromate results in increased expression of TRIAP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
EXP ISO |
potassium bromate results in increased expression of TRIB3 mRNA |
CTD |
PMID:23588252 PMID:30008028 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Ubd |
ubiquitin D |
increases expression |
EXP |
potassium bromate results in increased expression of UBD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
EXP |
Squalene inhibits the reaction [potassium bromate results in increased expression of VEGFA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vit |
vitrin |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of VIT mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:16,445,966...16,565,644
Ensembl chr 6:16,445,955...16,565,665
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of WARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
|
|
G |
Xdh |
xanthine dehydrogenase |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of XDH protein Taurine inhibits the reaction [potassium bromate results in increased activity of XDH protein] |
CTD |
PMID:25213677 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of XRCC3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions increases response to substance |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HCAR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SAA3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] |
CTD |
PMID:25693136 PMID:27082013 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
increases expression |
ISO |
potassium bromate results in increased expression of ZMAT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
|
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[sodium bromate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression |
EXP |
sodium chlorate results in decreased expression of BMP4 mRNA |
CTD |
PMID:12922982 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Cat |
catalase |
decreases activity |
EXP |
sodium chlorate results in decreased activity of CAT protein |
CTD |
PMID:28084674 PMID:30144278 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
sodium chlorate inhibits the reaction [CCL2 protein results in increased activity of CCR2 protein] |
CTD |
PMID:23408426 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
multiple interactions decreases sulfation |
ISO |
sodium chlorate inhibits the reaction [CCL2 protein results in increased activity of CCR2 protein] sodium chlorate results in decreased sulfation of CCR2 protein |
CTD |
PMID:23408426 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases activity |
EXP |
sodium chlorate results in decreased activity of FBP1 protein |
CTD |
PMID:28084674 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects activity |
ISO |
sodium chlorate affects the activity of FGF10 protein |
CTD |
PMID:12818887 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf23 |
fibroblast growth factor 23 |
multiple interactions |
ISO |
sodium chlorate inhibits the reaction [FGF23 protein results in decreased uptake of Phosphates] |
CTD |
PMID:27432882 |
|
NCBI chr 4:159,914,267...159,923,821
Ensembl chr 4:159,914,272...159,923,821
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
sodium chlorate inhibits the reaction [FSHB protein results in increased activity of PDE4A protein] |
CTD |
PMID:17261351 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases activity |
EXP |
sodium chlorate results in decreased activity of G6PD protein |
CTD |
PMID:28084674 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity |
EXP |
sodium chlorate results in decreased activity of GSR protein |
CTD |
PMID:28084674 PMID:30144278 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Kl |
Klotho |
decreases expression |
ISO |
sodium chlorate results in decreased expression of KL protein |
CTD |
PMID:27432882 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
sodium chlorate results in decreased phosphorylation of MAPK1 protein Heparin inhibits the reaction [sodium chlorate results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:19937756 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
Heparin inhibits the reaction [sodium chlorate results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:19937756 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nanog |
Nanog homeobox |
increases expression |
ISO |
sodium chlorate results in increased expression of NANOG mRNA |
CTD |
PMID:19937756 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Pde4a |
phosphodiesterase 4A |
multiple interactions |
EXP |
sodium chlorate inhibits the reaction [FSHB protein results in increased activity of PDE4A protein] |
CTD |
PMID:17261351 |
|
NCBI chr 8:19,690,816...19,753,538
Ensembl chr 8:19,703,290...19,751,961
|
|
G |
Sftpc |
surfactant protein C |
decreases expression |
EXP |
sodium chlorate results in decreased expression of SFTPC mRNA |
CTD |
PMID:12922982 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
ISO |
sodium chlorate inhibits the reaction [SLC5A5 protein results in increased uptake of perrhenate analog]; sodium chlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; sodium chlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Pertechnetate Tc 99m] |
CTD |
PMID:12488351 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Sodium Hypochlorite results in increased expression of ALPL mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Sodium Hypochlorite inhibits the reaction [bisphenol A binds to ESR2 protein]; Sodium Hypochlorite inhibits the reaction [Estradiol binds to ESR2 protein]; Sodium Hypochlorite inhibits the reaction [nonylphenol binds to ESR2 protein] |
CTD |
PMID:14723943 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
Sodium Hypochlorite promotes the reaction [[MPO protein results in increased oxidation of dibromoacetonitrile] which results in increased chemical synthesis of Cyanides]; Sodium Hypochlorite promotes the reaction [MPO protein results in increased oxidation of dibromoacetonitrile] |
CTD |
PMID:25614581 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
multiple interactions |
EXP |
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of ALDH1L1 protein |
CTD |
PMID:30090431 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
multiple interactions |
EXP |
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of ALDH5A1 protein |
CTD |
PMID:30090431 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
increases expression |
EXP |
sodium perchlorate results in increased expression of CGA mRNA; sodium perchlorate results in increased expression of CGA protein |
CTD |
PMID:29139221 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of CTH protein |
CTD |
PMID:30090431 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
EXP |
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of CYB5A protein |
CTD |
PMID:30090431 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases expression |
EXP |
sodium perchlorate results in decreased expression of DIO1 mRNA |
CTD |
PMID:29139221 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[sodium perchlorate results in increased abundance of perchlorate] which results in increased expression of FOS protein |
CTD |
PMID:30991129 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
multiple interactions |
EXP |
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in decreased expression of FTCD protein |
CTD |
PMID:30090431 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
multiple interactions |
EXP |
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of GAMT protein |
CTD |
PMID:30090431 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Ifng |
interferon gamma |
increases expression multiple interactions |
EXP |
sodium perchlorate results in increased expression of IFNG mRNA sodium perchlorate results in increased expression of and results in increased secretion of IFNG protein |
CTD |
PMID:29139221 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
EXP |
sodium perchlorate results in increased expression of IL1A mRNA |
CTD |
PMID:29139221 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
sodium perchlorate results in increased expression of and results in increased secretion of IL6 protein sodium perchlorate results in increased expression of IL6 mRNA |
CTD |
PMID:29139221 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Krt18 |
keratin 18 |
multiple interactions |
EXP |
[Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of KRT18 protein |
CTD |
PMID:30090431 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
[Iodine deficiency co-treated with sodium perchlorate] results in increased secretion of LEP protein |
CTD |
PMID:30090431 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
[Iodine deficiency co-treated with sodium perchlorate] results in decreased secretion of LHB protein |
CTD |
PMID:30090431 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Nkx2-1 |
NK2 homeobox 1 |
increases expression |
EXP |
sodium perchlorate results in increased expression of NKX2-1 protein |
CTD |
PMID:29139221 |
|
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
|
|
G |
Pax8 |
paired box 8 |
increases expression |
EXP |
sodium perchlorate results in increased expression of PAX8 protein |
CTD |
PMID:29139221 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Pon1 |
paraoxonase 1 |
multiple interactions |
EXP |
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of PON1 protein; [Iodine deficiency co-treated with sodium perchlorate] results in decreased expression of PON1 protein |
CTD |
PMID:30090431 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pon2 |
paraoxonase 2 |
multiple interactions |
EXP |
[[Iodine deficiency co-treated with sodium perchlorate] affects the susceptibility to hexabromocyclododecane] which results in increased expression of PON2 protein |
CTD |
PMID:30090431 |
|
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions increases expression decreases activity |
ISO EXP |
sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of perrhenate analog]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide analog]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Pertechnetate Tc 99m]; sodium perchlorate inhibits the reaction [SLC5A5 protein results in increased uptake of Technetium] sodium perchlorate results in increased expression of SLC5A5 mRNA; sodium perchlorate results in increased expression of SLC5A5 protein sodium perchlorate results in decreased activity of SLC5A5 protein |
CTD |
PMID:12488351 PMID:12489024 PMID:12541134 PMID:15221289 PMID:15520214 PMID:26827900 PMID:27979590 PMID:29139221 More...
|
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Tg |
thyroglobulin |
increases expression |
EXP |
sodium perchlorate results in increased expression of TG protein |
CTD |
PMID:29139221 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
EXP |
sodium perchlorate results in increased expression of TNF mRNA sodium perchlorate results in increased expression of and results in increased secretion of TNF protein |
CTD |
PMID:29139221 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tpo |
thyroid peroxidase |
decreases activity increases expression |
EXP |
sodium perchlorate results in decreased activity of TPO protein sodium perchlorate results in increased expression of TPO mRNA; sodium perchlorate results in increased expression of TPO protein |
CTD |
PMID:23959146 PMID:29139221 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Trh |
thyrotropin releasing hormone |
decreases expression increases expression |
EXP |
sodium perchlorate results in decreased expression of TRH protein sodium perchlorate results in increased expression of TRH mRNA |
CTD |
PMID:29139221 |
|
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions increases expression |
ISO EXP |
sodium perchlorate inhibits the reaction [efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]]; sodium perchlorate inhibits the reaction [Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]] [Iodine deficiency co-treated with sodium perchlorate] results in increased secretion of TSHB protein sodium perchlorate results in increased expression of TSHB mRNA; sodium perchlorate results in increased expression of TSHB protein |
CTD |
PMID:16030158 PMID:29139221 PMID:30090431 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
increases expression |
EXP |
sodium perchlorate results in increased expression of TSHR mRNA; sodium perchlorate results in increased expression of TSHR protein |
CTD |
PMID:29139221 |
|
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
|
|